We tested the IHC markers in a larger set of tumors that were nonetheless limited by a lack of CK20-negative MCC cases and CK20-positive SCLC cases, which impaired our ability to compare the sensitivity and specificity of MCC markers. The gene discussed is KRT20; the disease is small cell lung carcinoma.